Table 1.

Summary chemotherapy and immunotherapy agents received by patient 1

Treatments	Duration
Cisplatin, paclitaxela, gemcitabine	Six cycles
Nivolumab	28 cycles (56 weeks)b
Ipilimumab	2 cycles (6 weeks)c

^aPaclitaxel was stopped after first cycle due to grade 3 toxicity

^bAt the time of submission of this manuscript, 28 cycles were completed but nivolumab will be continued

^cAt the time of submission of this manuscript, 2 cycles were given and will be continued for 2 more cycles